AlphaHunt
Healthcare

HUM Stock Analysis

Humana Inc. · current price $362.31 (-1.90% today)

★★★★ Quality 67/ Alpha Score
Solid setup — 24% revenue growth, +19% 30-day momentum, 4/4 EPS beats. Caveat: trades 16.7% above analyst mean target. Stock is trading above the analyst mean target ($302) — limited consensus headroom.
LAST EARNINGS Humana Inc. (HUM)

Latest earnings

EPS
$6.27 vs $5.87 est · +0.1% vs estimate BEAT
Revenue
$39.65B · +22.4% YoY
Stock reaction (1M)
+18.6%
Beat streak
4 of last 4 quarters

Key metrics

Alpha Score
67/100
Grade
B
Rev Growth YoY
+23.5%
30-day Momentum
+18.6%
Forward P/E
38.6×
Analyst Target
$301.62
Implied Upside
-16.7%

Latest news on HUM

Similar stocks in Healthcare

BIIB WST LLY WAT MRNA DGX

View all Healthcare stocks →

HUM — frequently asked

What is HUM's Alpha Score?

Humana Inc. (HUM) currently has a TickerMover Alpha Score of 67/100, rated ★★★★ Quality. The Alpha Score is a quantitative composite across six research pillars — momentum, quality, growth, valuation, sentiment and risk. It is research information, not investment advice.

Is Humana Inc. (HUM) a buy?

TickerMover does not give buy or sell recommendations. HUM scores 67/100 (★★★★ Quality) on our quantitative research model — a screening signal, not a personal recommendation. Do your own research, and consider an FCA-authorised adviser before investing.

How often is HUM's score updated?

HUM's Alpha Score and underlying data refresh through US market hours (about every five minutes), using public market and fundamental data.

Get the full live dashboard

Real-time scoring, conflict detection, Reverse DCF, peer comparison and more — free during beta.

Open dashboard for HUM →